Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Emerg Infect Dis. 2006 Jan;12(1):55-60.

    Vaccines and antiviral drugs in pandemic preparedness.

    Source

    University of Michigan School of Public Health, Ann Arbor, Michigan 48109-2029, USA. asmonto@umich.edu

    Abstract

    While measures such as closing schools and social distancing may slow the effects of pandemic influenza, only vaccines and antiviral drugs are clearly efficacious in preventing infection or treating illness. Unless the pandemic strain closely resembles one already recognized, vaccine will not be available early. However, studies can be conducted beforehand to address questions concerning vaccine dose, frequency of inoculation, and need for adjuvants. In contrast, antiviral drugs, particularly the neuraminidase inhibitors, will be effective for treatment and available if stockpiling takes place. Special questions need to be answered if a highly lethal virus, such as influenza A (H5N1), produces the pandemic. Both vaccines and antiviral drugs will be required for a coordinated strategy.

    PMID:
    16494718
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3291404
    Free PMC Article

      Supplemental Content

      Icon for CDC-NCEZID Icon for PubMed Central

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk